GET ALL THREE SWITCHES FLIPPED AT ONCE.
Dubbed “Triple G” by researchers, Retatrutide is a triple agonist peptide that activates GLP-1, GIP, and glucagon receptors — each with its own potent metabolic effects.
GLP-1 suppresses appetite and stabilizes blood sugar. GIP improves insulin secretion. Glucagon increases fat oxidation and energy expenditure. Together, they create a powerful synergy for advanced fat loss, glucose regulation, and cardiometabolic support.
What’s more? Clinical trials have shown weight loss greater than 24% of body weight over 48 weeks, surpassing even the most hyped peptides of recent years.
What Is Retatrutide?
Retatrutide is a synthetic peptide designed to bind and activate three key hormone receptors:
- GLP-1R (Glucagon-like peptide-1 receptor)
- GIPR (Glucose-dependent insulinotropic polypeptide receptor)
- GCGR (Glucagon receptor)
This trio triggers powerful downstream effects: reduced appetite, slower gastric emptying, improved insulin sensitivity, and increased resting metabolic rate. It’s designed for individuals with obesity, insulin resistance, or metabolic syndrome who are seeking sustainable and medically supported weight loss.
What the Research and Users Report
Rapid, Consistent Fat Loss
Many users report appetite suppression within days, and visible fat reduction in the first 6–8 weeks.
Blood Sugar Regulation
Retatrutide improves insulin sensitivity and lowers fasting glucose levels, even in non-diabetics.
Enhanced Energy and Fat Oxidation
Glucagon receptor activation increases metabolic rate, helping prevent the slowdown often seen with calorie restriction.
Cardiometabolic Support
Reductions in triglycerides, waist circumference, and blood pressure have been observed in trials.
Inferred and Emerging Benefits
- May reduce inflammation and improve cardiovascular risk markers
- Enhances adherence to fasting or ketogenic diets by blunting hunger
- Promising adjunct to PCOS, NAFLD, and pre-diabetes protocols
Dosing & Protocol (Experimental)
Subcutaneous (SQ) Injection
Reconstitution:
– 5 mg vial → 2.0 mL bacteriostatic water
– 10 mg vial → 2.0 mL bacteriostatic water
Weekly Dose
- 5 mg vial → 1.0 mg (40 units)
- 10 mg vial → 1.0 mg (20 units)
Cycle:
– Inject once weekly on your chosen day (e.g. every Monday)
– 1 mg once weekly for weeks 1 and 2
– 2 mg once weekly for weeks 3 and 4
– After 4 weeks, may increase up to 4 mg per week, as needed
– Do not exceed 4 mg per week
– Take on the same day and time each week for stable blood levels
Timing: Take at the same time each week to maintain stable plasma levels. Preferably in the morning on an empty stomach, or as directed by your practitioner.
Smart Stacking
Retatrutide synergizes with several advanced peptides and metabolic agents:
- Cagrilintide: For amplified appetite suppression and satiety
- 5-Amino-1MQ: To boost fat metabolism and support NAD+ levels
- AOD-9604: For lipolysis and fat loss without affecting lean muscle mass
This triple-action stack can be tailored for aggressive fat loss protocols, plateau busting, or metabolic recovery phases.
Potential Side Effects & Considerations
Some users may experience transient effects, especially during dose titration:
- Nausea or vomiting, especially at higher doses
- Mild headache, fatigue, or constipation
- Injection site irritation
- Hypoglycemia risk when used with other glucose-lowering drugs
Start with low doses and increase gradually. Rotating injection sites and staying hydrated may reduce side effects.
Is Retatrutide Worth It?
For those with stubborn weight, insulin resistance, or metabolic dysfunction, Retatrutide offers one of the most potent peptide therapies yet. With its multi-receptor targeting, it doesn’t just help with weight loss — it reprograms your metabolism.
It’s best used in a supportive context: healthy eating, regular movement, and practitioner-guided monitoring. But when used correctly, it may be the most complete metabolic reset available today.
Disclaimer
This article is for educational purposes only and is not intended as medical advice. Retatrutide is an experimental compound not yet approved for general clinical use. Always consult with a licensed healthcare provider before beginning any peptide or metabolic protocol. All Pep Hub products are sold for laboratory research use only — not for human or veterinary use.
Research-grade, third-party verified
Every batch is tested, and the reports live in The Receipts. Check your lot any time with Check Your Vial.
- Retatrutide — $90 CAD
- Cagrilintide — $105 CAD
- 5-Amino-1MQ — $125 CAD
- NAD+ — $108 CAD
- AOD-9604 — $45 CAD